Disaccharidase deficiency and functional bowel diseases


Cite item

Full Text

Abstract

Aim. To elucidate the role of intestinal carbohydrases (glucoamylase, maltase, sucrose, and lactase) in the etiology and pathogenesis of functional bowel diseases (FBD). Subjects and methods. 74 patients (36 men and 38 women) aged 18 to 50 years with FBD were examined. According to Rome IV criteria (2016), there was diarrhea-predominant irritable bowel syndrome (IBS) in 21 patients, functional diarrhea (FD) in 33, constipation-predominant IBS in 6, functional constipation (FC) in 4, and mixed IBS in 10. The activity of carbohydrases in the small intestine mucosa (SIM) was investigated by the Dahlquist method modified by Trinder in the duodenal biopsy specimens obtained during esophagogastroduodenoscopy. Results. Lactase deficiency was identified in 87.8% of the patients; maltase deficiency in 48.6%; sucrose deficiency in 51.3%; and glucoamylase deficiency in 85.1%. The activity of all the investigated enzymes was reduced in 23 (31.1%) patients with FBD; deficiency of 1—3 carbohydrases was found in 47 (63.5%). Normal enzymatic activity was established in 4 (5.4%) patients. Conclusion. In the majority of patients with FBD, the intestinal symptoms are caused by the decreased activity of SIM carbohydrases. Therefore, disaccharidase deficiency associated with an established damaging agent (nonsteroidal anti-inflammatory drugs, antibiotics, acute intestinal infections, etc.) should be considered to be a more precise diagnosis.

About the authors

A I Parfenov

ГБУЗ города Москвы «Московский клинический научно-практический центр ДЗМ»

Москва, Россия

O V Akhmadullina

ГБУЗ города Москвы «Московский клинический научно-практический центр ДЗМ»

Москва, Россия

E A Sabelnikova

ГБУЗ города Москвы «Московский клинический научно-практический центр ДЗМ»

Москва, Россия

N I Belostotsky

ГБУЗ города Москвы «Московский клинический научно-практический центр ДЗМ»

Москва, Россия

M V Kirova

ГБУЗ города Москвы «Московский клинический научно-практический центр ДЗМ»

Москва, Россия

S G Khomeriki

ГБУЗ города Москвы «Московский клинический научно-практический центр ДЗМ»

Москва, Россия

S V Bykova

ГБУЗ города Москвы «Московский клинический научно-практический центр ДЗМ»

Москва, Россия

References

  1. Drossman DA, Hasler WL. Rome IV—Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology. 2016; 150:1257-1261. doi: 10.1053/j.gastro.2016.03.035
  2. Lacy BE, Mearin F, Chang L, et al. Bowel disorders. Gastroenterology. 2016;150:1393-1407. doi: 10.1053/j.gastro.2016.02.031
  3. Парфенов А.И. К 50-летию создания А.М. Уголевым современной теории пищеварения (передовая). Тер. архив. 2010;82(2):5-10.
  4. Dahlqvist A. Specificity of the human intestinal disaccharidases and implications for hereditary disaccharide intolerance. Journal of Clinical Investigation. 1962;41:3-8.
  5. Trinder P. Depermination of glucosa in blood using glucosa oxidase with an alternative oxigen reception. J Ann Clin Biochem. 1969;6:24-27.
  6. Парфенов А.И., Ахмадуллина О.В., Сабельникова Е.А., Белостоцкий Н.И., Гудкова Р.Б., Хомерики С.Г. Активность карбогидраз как маркер восстановления слизистой оболочки тонкой кишки у больных целиакией. Тер. архив. 2015;87(2): 24-29.
  7. Farup PG, Monsbakken KW, Vandvik PO. Lactose malabsorption in a population with irritable bowel syndrome: prevalence and symptoms. A case-control study. Scandinavian Journal of Gastroenterology. 2004;39(7):645-649. doi: 10.1080/00365520410005405
  8. Pawłowska K, Umławska W, Iwańczak B. Prevalence of Lactose Malabsorption and Lactose Intolerance in Pediatric Patients with Selected Gastrointestinal Diseases. Advances in Clinical and Experimental Medicine. 2015;24(5):863-871. doi: 10.17219/acem/26337
  9. Yakoob J, Abbas Z, Khan R, Hamid S, Awan S, and Jafri W. Small Intestinal Bacterial Overgrowth and Lactose Intolerance Contribute to Irritable Bowel Syndrome Symptomatology in Pakistan. Saudi Journal of Gastroenterology. 2011;17(6):371-375. doi: 10.4103/1319-3767.87176
  10. Фадеева Н.А., Ручкина И.Н., Парфенов А.И., Щербаков П.Л. Избыточный рост микрофлоры тонкой кишки как причина лактазной недостаточности. Тер. архив. 2015;87(2):20-23. doi: 10.17116/terarkh20158720-23
  11. Nichols BL, Jr, Adams B, Roach CM, Ma CX, Baker SS. Frequency of sucrase deficiency in mucosal biopsies. Journal of Pediatric Gastroenterology and Nutrition. 2012;55(Suppl.2):S28-S30. doi: 10.1097/01.mpg.0000421405.42386.64
  12. Gericke B, Amiri M, Naim HY. The multiple roles of sucrase-isomaltase in the intestinal physiology. Molecular and Cellular Pediatrics. 2016;3(1):2. doi: 10.1186/s40348-016-0033-y
  13. Parker TJ, Woolner JT, Prevost AT, Tuffnell Q, Shorthouse M, Hunter JO. Irritable bowel syndrome: is the search for lactose intolerance justified? European Journal of Gastroenterology & Hepatology. 2001;13(3):219-225. doi: 10.1097/00042737-200103000-00001
  14. Fritz E, Hammer J, Vogelsang H. Fructose-free diet does not improve GI symptoms in fructose-intolerant patients if irritable bowel syndrome is present. Gastroenterology. 2003;124(4):A434. doi: 10.1016/s0016-5085(03)82194-7
  15. Staudacher HM, Whelan K, Irving PM, Lomer MC. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. Journal of human nutrition and dietetics. 2011;24:487-495. doi: 10.1111/j.1365-277X.2011.01162.x
  16. Shepherd SJ, Lomer MC, Gibson PR. Short-chain carbohydrates and functional gastrointestinal disorders. The American Journal of Gastroenterology. 2013;108:707-717. doi: 10.1038/ajg.2013.96
  17. Staudacher HM, Whelan K, Irving PM, et al. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. Journal of Human Nutrition and Dietetics. 2011;24:487-495. doi: 10.1111/j.1365-277x.2011.01162.x
  18. Mizukami K, Murakami K, Abe T, Inoue K, Uchida M, Okimoto T, Kodama M, Fujioka T. Aspirin-induced small bowel injuries and the preventive effect of rebamipide. World J Gastroenterol. 2011;17(46):5117-5122. doi: 10.3748/wjg.v17.i46.5117
  19. Zhang S, Qing Q, Bai Y. Rebamipide helpsd efend against nonsteroidal anti-inflammatory drugs induced gastroenteropathy: A systematic review and meta-analysis. Dig Dis Sci. 2013;7:1991-2000. doi: 10.1007/s10620-013-2606-0

Copyright (c) 2017 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies